title: Investigation of oncogenic cooperation in simple liver-specific transgenic mouse models using noninvasive in vivo imaging.
abstract: Liver cancer is a complex multistep process requiring genetic alterations in multiple proto-oncogenes and tumor suppressor genes. Although hundreds of genes are known to play roles in hepatocarcinogenesis, oncogenic collaboration among these genes is still largely unknown. Here, we report a simple methodology by which oncogenic cooperation between cancer-related genes can be efficiently investigated in the liver. We developed various non-germline transgenic mouse models using hydrodynamics-based transfection which express HrasG12V, SmoM2, and a short-hairpin RNA down-regulating p53 (shp53) individually or in combination in the liver. In this transgenic system, firefly luciferase was co-expressed with the oncogenes as a reporter, allowing tumor growth in the liver to be monitored over time without an invasive procedure. Very strong bioluminescence imaging (BLI) signals were observed at 4 weeks post-hydrodynamic injection (PHI) in mice co-expressing HrasG12V and shp53, while only background signals were detected in other double or single transgenic groups until 30 weeks PHI. Consistent with the BLI data, tumors were observed in the HrasG12V plus shp53 group at 4 weeks PHI, while other transgenic groups failed to exhibit a hyperplastic nodule at 30 weeks PHI. In the HrasG12V plus shp53 transgenic group, BLI signals were well-correlated with actual tumor growth in the liver, confirming the versatility of BLI-based monitoring of tumor growth in this organ. The methodology described here is expected to accelerate and facilitate in vivo studies of the hepatocarcinogenic potential of cancer-related genes by means of oncogenic cooperation.
authors.affiliation: Liver Cirrhosis Clinical Research Center, Yonsei University College of Medicine, Seoul, Korea.
authors.forename: Hye-Lim
authors.initials: HL
authors.lastname: Ju
authors.forename: Sang Hoon
authors.initials: SH
authors.lastname: Ahn
authors.forename: Do Young
authors.initials: DY
authors.lastname: Kim
authors.forename: Sinhwa
authors.initials: S
authors.lastname: Baek
authors.forename: Sook In
authors.initials: SI
authors.lastname: Chung
authors.forename: Jinsil
authors.initials: J
authors.lastname: Seong
authors.forename: Kwang-Hyub
authors.initials: KH
authors.lastname: Han
authors.forename: Simon Weonsang
authors.initials: SW
authors.lastname: Ro
mesh_terms: D000818:Animals; D006528:Carcinoma, Hepatocellular / Q000378:metabolism*; D004195:Disease Models, Animal; D015972:Gene Expression Regulation, Neoplastic; D057446:Hydrodynamics; D008113:Liver Neoplasms / Q000378:metabolism / Q000473:pathology*; D008156:Luciferases; D049449:Luminescence; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D008856:Microscopy, Fluorescence; D041681:NIH 3T3 Cells; D009857:Oncogenes; D010957:Plasmids; D013997:Time Factors; D014162:Transfection; D051598:Whole Body Imaging
chemical_list: D008156:Luciferases
references.citation: Int J Exp Pathol. 2009 Aug;90(4):367-86
references.pmid: 19659896
references.citation: Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4254-9
references.pmid: 19246386
references.citation: Gene Ther. 2007 Jan;14(2):99-107
references.pmid: 17167496
references.citation: Development. 1997 Apr;124(7):1313-22
references.pmid: 9118802
references.citation: Mol Ther. 2010 Oct;18(10):1796-802
references.pmid: 20628359
references.citation: Eur J Cancer. 2002 Nov;38(16):2128-36
references.pmid: 12387838
references.citation: Liver Int. 2008 Feb;28(2):160-74
references.pmid: 18069974
references.citation: Nat Rev Cancer. 2010 Jul;10(7):470-80
references.pmid: 20574449
references.citation: Gastroenterology. 2007 Jun;132(7):2557-76
references.pmid: 17570226
references.citation: FEBS Lett. 1997 May 5;407(3):313-9
references.pmid: 9175875
references.citation: Nat Protoc. 2007;2(12):3153-65
references.pmid: 18079715
references.citation: Cancer Res. 2009 Jan 15;69(2):431-9
references.pmid: 19147555
references.citation: Lancet Oncol. 2002 Sep;3(9):546-56
references.pmid: 12217792
references.citation: PLoS One. 2012;7(2):e30432
references.pmid: 22319569
references.citation: Gastroenterology. 2006 Apr;130(4):1117-28
references.pmid: 16618406
references.citation: J Hepatol. 2009 Oct;51(4):725-33
references.pmid: 19665249
references.citation: Semin Liver Dis. 2010 Feb;30(1):75-86
references.pmid: 20175035
references.citation: Mol Ther. 2009 Jul;17(7):1136-44
references.pmid: 19384290
references.citation: Semin Liver Dis. 2011 May;31(2):173-87
references.pmid: 21538283
references.citation: Hum Gene Ther. 1999 Jul 1;10(10):1735-7
references.pmid: 10428218
references.citation: J Mol Biol. 2002 May 17;318(5):1221-35
references.pmid: 12083513
references.citation: Nature. 1998 Jan 1;391(6662):90-2
references.pmid: 9422511
references.citation: J Hepatol. 2008 May;48(5):858-79
references.pmid: 18314222
references.citation: Cell. 1997 Nov 14;91(4):501-10
references.pmid: 9390559
references.citation: Hum Gene Ther. 2010 Feb;21(2):210-20
references.pmid: 19761403
references.citation: J Hepatol. 2010 Jun;52(6):921-9
references.pmid: 20385424
references.citation: Cell. 2006 Jun 30;125(7):1253-67
references.pmid: 16814713
references.citation: Nat Rev Cancer. 2005 Oct;5(10):796-806
references.pmid: 16195751
references.citation: Adv Genet. 2005;54:189-232
references.pmid: 16096013
references.citation: J Pathol. 2010 Feb;220(3):317-27
references.pmid: 19967724
references.citation: Mol Ther. 2003 Jul;8(1):108-17
references.pmid: 12842434